Metformin sensitizes <scp>AML</scp> cells to venetoclax through endoplasmic reticulum stress—<scp>CHOP</scp> pathway
2023 · British Journal of Haematology · 16 citations
https://doi.org/10.1111/bjh.18968
N
Nianhui Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
50
Citations
4
h-index
2
i10-index
Nianhui Yang is an academic researcher from First Affiliated Hospital of Jinan University. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Autophagy in Disease and Therapy & COVID-19 Clinical Research Studies. The author has an h-index of 4, co-authored 7 publications.
Papers by this author
worksThe effects of daratumumab on bone disease in patients with newly diagnosed multiple myeloma: a multi-center retrospective study
2025 · BMC Cancer · 0 citations
https://doi.org/10.1186/s12885-025-15250-1
Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication
2026 · Cell Reports · 0 citations
https://doi.org/10.1016/j.celrep.2026.117021
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat